155 related articles for article (PubMed ID: 38042213)
1. LINC00319: Unraveling the spectrum from gene regulation to clinical applications in cancer progression.
Su X; Yan L; Si J; Wang Z; Liang C; Peng K; Shen J; Duan S
Gene; 2024 Feb; 896():148044. PubMed ID: 38042213
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p/NACC1 pathway.
Du W; Feng Z; Sun Q
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):198-202. PubMed ID: 30442370
[TBL] [Abstract][Full Text] [Related]
3. LINC00319 acts as a
Zou J; Wu K; Lin C; Jie ZG
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G10-G22. PubMed ID: 31433213
[TBL] [Abstract][Full Text] [Related]
4. CCL18-induced LINC00319 promotes proliferation and metastasis in oral squamous cell carcinoma via the miR-199a-5p/FZD4 axis.
Jiang X; Liu J; Li S; Jia B; Huang Z; Shen J; Luo H; Zhao J
Cell Death Dis; 2020 Sep; 11(9):777. PubMed ID: 32948745
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis.
Yang Y; Zhang F; Huang H; Xie Z; Huang W; Xie H; Wang F
J Cell Physiol; 2020 Apr; 235(4):3768-3775. PubMed ID: 31608995
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
7. LINC00319 promotes osteosarcoma progression by regulating the miR-455-3p/NFIB axis.
Sun F; Yu Z; Wu B; Zhang H; Ruan J
J Gene Med; 2020 Nov; 22(11):e3248. PubMed ID: 32621625
[TBL] [Abstract][Full Text] [Related]
8. MYC upregulated LINC00319 promotes human acute myeloid leukemia (AML) cells growth through stabilizing SIRT6.
Zhang Y; Huang Z; Sheng F; Yin Z
Biochem Biophys Res Commun; 2019 Jan; 509(1):314-321. PubMed ID: 30587342
[TBL] [Abstract][Full Text] [Related]
9. Long intergenic non-protein coding RNA 319 aggravates lung adenocarcinoma carcinogenesis by modulating miR-450b-5p/EZH2.
Zhang ZW; Chen JJ; Xia SH; Zhao H; Yang JB; Zhang H; He B; Jiao J; Zhan BT; Sun CC
Gene; 2018 Apr; 650():60-67. PubMed ID: 29408583
[TBL] [Abstract][Full Text] [Related]
10. LINC00319 promotes cancer stem cell-like properties in laryngeal squamous cell carcinoma via E2F1-mediated upregulation of HMGB3.
Yuan L; Tian X; Zhang Y; Huang X; Li Q; Li W; Li S
Exp Mol Med; 2021 Aug; 53(8):1218-1228. PubMed ID: 34408262
[TBL] [Abstract][Full Text] [Related]
11. LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis.
Yang J; Hou S; Liang B
In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):145-153. PubMed ID: 31942724
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA 319 facilitates nasopharyngeal carcinoma carcinogenesis through regulation of miR-1207-5p/KLF12 axis.
Song P; Yin SC
Gene; 2019 Jan; 680():51-58. PubMed ID: 30243935
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00319 is associated with tumorigenesis and poor prognosis in glioma.
Li Q; Wu Q; Li Z; Hu Y; Zhou F; Zhai Z; Yue S; Tian H
Eur J Pharmacol; 2019 Oct; 861():172556. PubMed ID: 31325436
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
15. Biological role of long non-coding RNA KCNQ1OT1 in cancer progression.
Zhan K; Pan H; Zhou Z; Tang W; Ye Z; Huang S; Luo L
Biomed Pharmacother; 2023 Dec; 169():115876. PubMed ID: 37976888
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control.
Taheriazam A; Bayanzadeh SD; Heydari Farahani M; Mojtabavi S; Zandieh MA; Gholami S; Heydargoy MH; Jamali Hondori M; Kangarloo Z; Behroozaghdam M; Khorrami R; Sheikh Beig Goharrizi MA; Salimimoghadam S; Rashidi M; Hushmandi K; Entezari M; Hashemi M
Eur J Pharmacol; 2023 Jul; 951():175781. PubMed ID: 37179043
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
[TBL] [Abstract][Full Text] [Related]
18. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA.
Zhou H; Gao Z; Wan F
Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):123-130. PubMed ID: 30590378
[TBL] [Abstract][Full Text] [Related]
19. p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy.
Yang K; Xiao Y; Zhong L; Zhang W; Wang P; Ren Y; Shi L
Cancer Gene Ther; 2023 Nov; 30(11):1456-1470. PubMed ID: 37679529
[TBL] [Abstract][Full Text] [Related]
20. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
